Xing Niu - Search Results

Year	Number of Results
2019	5
2020	13
2021	8
2022	5
2023	11
2024	2

1

Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.

Niu X, Chen L, Li Y, Hu Z, He F. Niu X, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):273-285. doi: 10.1016/j.semcancer.2022.03.009. Epub 2022 Mar 12. Semin Cancer Biol. 2022. PMID: 35288298 Review.

2

Crosstalk between 5-methylcytosine and N⁶-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma.

Tian Y, Xiao H, Yang Y, Zhang P, Yuan J, Zhang W, Chen L, Fan Y, Zhang J, Cheng H, Deng T, Yang L, Wang W, Chen G, Wang P, Gong P, Niu X, Zhang X. Tian Y, et al. Among authors: niu x. Mol Cancer. 2023 Jan 10;22(1):5. doi: 10.1186/s12943-022-01706-6. Mol Cancer. 2023. PMID: 36627693 Free PMC article.

3

Towards functional precision oncology with human organoids.

Wang Z, Niu X, Cui C, Ouyang M, Li Q, Li Z, Liang L. Wang Z, et al. Among authors: niu x. Lancet. 2023 Oct 28;402(10412):1526-1527. doi: 10.1016/S0140-6736(23)01699-9. Epub 2023 Sep 22. Lancet. 2023. PMID: 37748492 No abstract available.

4

Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology.

Wang Z, Liu Y, Niu X. Wang Z, et al. Among authors: niu x. Semin Cancer Biol. 2023 Aug;93:83-96. doi: 10.1016/j.semcancer.2023.04.009. Epub 2023 Apr 26. Semin Cancer Biol. 2023. PMID: 37116818 Review.

5

Characterization of the Nucleus Pulposus Progenitor Cells via Spatial Transcriptomics.

Chen Y, Zhang L, Shi X, Han J, Chen J, Zhang X, Xie D, Li Z, Niu X, Chen L, Yang C, Sun X, Zhou T, Su P, Li N, Greenblatt MB, Ke R, Huang J, Chen ZS, Xu R. Chen Y, et al. Among authors: niu x. Adv Sci (Weinh). 2024 Feb 4:e2303752. doi: 10.1002/advs.202303752. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38311573

6

Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling.

Xi Y, Shen Y, Chen L, Tan L, Shen W, Niu X. Xi Y, et al. Among authors: niu x. Cytokine Growth Factor Rev. 2023 Oct;73:78-92. doi: 10.1016/j.cytogfr.2023.08.010. Epub 2023 Aug 30. Cytokine Growth Factor Rev. 2023. PMID: 37696716 Review.

7

Application of nanomaterials in diagnosis and treatment of glioblastoma.

Yu S, Chen L, Xu H, Long S, Jiang J, Wei W, Niu X, Li X. Yu S, et al. Among authors: niu x. Front Chem. 2022 Dec 9;10:1063152. doi: 10.3389/fchem.2022.1063152. eCollection 2022. Front Chem. 2022. PMID: 36569956 Free PMC article. Review.

8

Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.

Xi Y, Chen L, Tang J, Yu B, Shen W, Niu X. Xi Y, et al. Among authors: niu x. Immunol Rev. 2024 Jan;321(1):94-114. doi: 10.1111/imr.13251. Epub 2023 Aug 7. Immunol Rev. 2024. PMID: 37550950 Review.

9

EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies.

Zhu X, Chen L, Liu L, Niu X. Zhu X, et al. Among authors: niu x. Front Oncol. 2019 Oct 11;9:1044. doi: 10.3389/fonc.2019.01044. eCollection 2019. Front Oncol. 2019. PMID: 31681582 Free PMC article. Review.

10

Mitochondrial unfolded protein response in ischemia-reperfusion injury.

Zhu MX, Ma XF, Niu X, Fan GB, Li Y. Zhu MX, et al. Among authors: niu x. Brain Res. 2022 Dec 15;1797:148116. doi: 10.1016/j.brainres.2022.148116. Epub 2022 Oct 6. Brain Res. 2022. PMID: 36209898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year